Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.

Research square·2026

Same author

Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Nature·2026

Same author

pyVIPER: a fast and scalable Python package for protein activity estimation and master regulator analysis of single-cell RNA sequencing data.

BMC bioinformatics·2026

Same author

Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

JCO precision oncology·2026

Same author

A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.

The Journal of experimental medicine·2026

Same author

Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.

Nature genetics·2026

Search research articles

Related Experiment Video

Updated: May 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Improving breast cancer survival analysis through competition-based multidimensional modeling.

Erhan Bilal¹, Janusz Dutkowski, Justin Guinney

¹IBM TJ Watson Research, Yorktown Heights, New York, USA.

Plos Computational Biology

|May 15, 2013

Summary

Machine learning models incorporating expert-selected molecular features improve breast cancer survival predictions. Ensemble models and competition-based approaches enhance accuracy for better breast cancer treatment strategies.

Related Experiment Videos

Last Updated: May 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

Oncology
Bioinformatics
Computational Biology

Background:

Breast cancer is a leading cause of death in women, characterized by significant heterogeneity.
Accurate prognosis based on molecular and phenotypic features is crucial for tailoring breast cancer treatments.
Understanding subtype-specific prognoses can improve patient outcomes.

Purpose of the Study:

To develop and evaluate machine learning models for breast cancer prognosis prediction.
To leverage genomic and clinical data within a competition framework to optimize predictive models.
To identify effective strategies for prognostic model development using molecular profiling data.

Main Methods:

Utilized a competition-based approach with an online leaderboard for rapid feedback and model improvement.
Employed machine learning techniques on large datasets of genomic and clinical information.
Integrated molecular features selected based on expert prior knowledge.

Main Results:

Machine learning models combined with expert-prioritized molecular features surpassed current best-in-class survival prediction methods.
Ensemble models, aggregating multiple user submissions, consistently outperformed individual models.
Model performance demonstrated high consistency across independent evaluations.

Conclusions:

Machine learning, guided by expert knowledge, offers a powerful approach to enhancing breast cancer survival prediction.
Competition-driven development and ensemble methods are effective strategies for optimizing prognostic models.
This pilot study lays the groundwork for a larger community-driven effort to advance breast cancer prognostication.